Hansa Biopharma AB (publ)

OM:HNSA Stock Report

Market Cap: SEK 2.2b

Hansa Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HNSA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,849,4674.2%
Individual Insiders5,319,0427.84%
Institutions10,949,53616.1%
Hedge Funds21,404,30031.6%
General Public27,291,89640.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.3%.

Top Shareholders

Top 25 shareholders own 63.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.4%
Redmile Group, LLC
13,156,700SEK 421.5m0%2.43%
12.2%
Braidwell LP
8,247,600SEK 264.3m0%1.1%
4.01%
Theodor Jeansson
2,720,000SEK 87.1m-0.37%no data
3.25%
Hansa Biopharma
2,204,667SEK 70.6m-0.43%no data
3.18%
Nexttobe AB
2,155,379SEK 69.1m0%79.76%
3.09%
Fourth Swedish National Pension Fund (AP4)
2,094,000SEK 67.1m0%0.03%
2.83%
Thomas Olausson
1,917,000SEK 61.4m0%no data
2.81%
Avanza Fonder AB
1,906,416SEK 61.1m-1.22%0.05%
2.54%
Handelsbanken Asset Management
1,724,561SEK 55.3m96.2%0.01%
2.05%
Tredje AP-fonden
1,389,600SEK 44.5m0%0.02%
1.63%
Sphera Funds Management Ltd
1,107,000SEK 35.5m0%0.56%
1.18%
C WorldWide Asset Management Fondsmaeglerselskab A/S
799,749SEK 25.6m0%0.02%
1.07%
Max Mitteregger Kapitalforvaltning AB
725,000SEK 23.2m0%100.0%
0.95%
Vob & T Trading AB
644,800SEK 20.7m0%no data
0.88%
William Gunnarsson
600,000SEK 19.2m0%no data
0.55%
SEB Investment Management AB
370,194SEK 11.9m3.27%no data
0.42%
Norges Bank Investment Management
285,729SEK 9.2m0%no data
0.29%
FCG Fonder AB
197,538SEK 6.3m0%0.07%
0.27%
Storebrand Fonder AB,
186,177SEK 6.0m0%no data
0.27%
Skandia Fonder AB
183,643SEK 5.9m0%no data
0.25%
E. Öhman J:or Wealth Management
167,154SEK 5.4m0%no data
0.23%
State Street Global Advisors, Inc.
159,070SEK 5.1m1.66%no data
0.085%
Søren Tulstrup
57,542SEK 1.8m0%no data
0.036%
Peter Nicklin
24,500SEK 785.0k0%no data
0.0048%
Assenagon Asset Management S.A.
3,256SEK 104.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 06:23
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hansa Biopharma AB (publ) is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Christian LeeABG Sundal Collier Sponsored
Madhu KumarB. Riley Securities, Inc.